Award
Delivery Order #SPE2DR26F1ZPM
Delivery Order for Atrovent Inhalers Under AmerisourceBergen Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$163.17
Ceiling
$163.17
Awarded
June 11, 2026
Period of Performance
Jun 11, 2026 – Jun 12, 2026
Identifier
SPE2DR26F1ZPM
NAICS
424210
This government award represents a delivery order contract issued to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor, under an existing indefinite delivery vehicle (IDV) dedicated to pharmaceutical distribution. The contract procures Atrovent 17 MCG HFA inhalers, a vital respiratory medication essential for public health and healthcare readiness. This delivery order, competitively awarded under the umbrella IDV, supports the agency's continuous access to critical medications by ensuring the timely delivery of specified quantities within a brief performance window. The award aligns with a multi-year IDV established to guarantee uninterrupted supply chains for essential pharmaceuticals, reflecting the agency's dedication to maintaining healthcare accessibility. The parent contract is a long-term IDV awarded to AmerisourceBergen, reinforcing their role as a key supplier of vital pharmaceutical products to various healthcare facilities.
Description
4572101336!ATROVENT 17 MCG HFA INHALER 12.9GM